PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 21177434-2 2011 Herein, four 5-LOX-derived lipids comprising 5-hydroxyeicosatetraenoic acid (HETE) attached to phospholipids (PLs), either phosphatidylethanolamine (PE) or phosphatidylcholine (18:0p/5-HETE-PE, 18:1p/5-HETE-PE, 16:0p/5-HETE-PE, and 16:0a/5-HETE-PC), were identified in primary human neutrophils. Phospholipids 95-108 arachidonate 5-lipoxygenase Homo sapiens 13-18 21177434-2 2011 Herein, four 5-LOX-derived lipids comprising 5-hydroxyeicosatetraenoic acid (HETE) attached to phospholipids (PLs), either phosphatidylethanolamine (PE) or phosphatidylcholine (18:0p/5-HETE-PE, 18:1p/5-HETE-PE, 16:0p/5-HETE-PE, and 16:0a/5-HETE-PC), were identified in primary human neutrophils. Phospholipids 110-113 arachidonate 5-lipoxygenase Homo sapiens 13-18 15923196-1 2005 5-Lipoxygenase (5-LO) catalysis is positively regulated by Ca2+ ions and phospholipids that both act via the N-terminal C2-like domain of 5-LO. Phospholipids 73-86 arachidonate 5-lipoxygenase Homo sapiens 0-14 15572846-8 2004 Since the 5-lipoxygenase pathway is abundantly expressed in atherosclerotic lesions, and 12/15-lipoxygenase is able to oxygenate polyunsaturated fatty acid esterified in the membranous phospholipids, 5-lipoxygenase or 12/15-lipoxygenase inhibitors may prevent progression of atherosclerosis. Phospholipids 185-198 arachidonate 5-lipoxygenase Homo sapiens 10-24 15572846-8 2004 Since the 5-lipoxygenase pathway is abundantly expressed in atherosclerotic lesions, and 12/15-lipoxygenase is able to oxygenate polyunsaturated fatty acid esterified in the membranous phospholipids, 5-lipoxygenase or 12/15-lipoxygenase inhibitors may prevent progression of atherosclerosis. Phospholipids 185-198 arachidonate 5-lipoxygenase Homo sapiens 93-107 15366660-4 2003 Leukotrienes are synthesized through the 5-lipoxygenase pathway from the arachidonic acid which is released from the phospholipids forming the membrane of activated cells. Phospholipids 117-130 arachidonate 5-lipoxygenase Homo sapiens 41-55 9620944-1 1998 Cytosolic phospholipase A2 translocates from the cytoplasm to selectively hydrolyze nuclear envelope phospholipids, releasing free arachidonate. 5-Lipoxygenase-activating protein, an arachidonate transfer protein, then binds arachidonate and presents it to 5-lipoxygenase (5-LO), which catalyzes a two-step reaction to produce leukotriene A4. In resting human and rat peripheral blood neutrophils, 5-LO is localized to the cytoplasm; in rat basophilic leukemia cells and human alveolar macrophages, however, it is found predominantly in the nucleus. Phospholipids 102-115 arachidonate 5-lipoxygenase Homo sapiens 146-160 7577949-5 1995 Photoaffinity labeling of 5-lipoxygenase by L-708,714 was dependent on the presence of both Ca2+ ions and phospholipids and was independent of ATP. Phospholipids 106-119 arachidonate 5-lipoxygenase Homo sapiens 26-40 7900879-1 1995 5-Lipoxygenase (5-LO) converts arachidonic acid, released from membrane phospholipids upon external stimulation, to leukotriene C4 (LTC4), which induces various kinds of cellular and molecular responses. Phospholipids 72-85 arachidonate 5-lipoxygenase Homo sapiens 0-14 8395245-2 1993 The enzymatic activity of purified human 5-lipoxygenase was dependent on the ratio of arachidonic acid to phospholipids rather than on the bulk arachidonic acid concentration, suggesting that the concentration of substrate at the lipid-water interface is important for the rate of the 5-LO reaction. Phospholipids 106-119 arachidonate 5-lipoxygenase Homo sapiens 41-55 8395245-6 1993 The data are consistent with the catalysis of 5-LO occurring at the surface of phospholipid vesicles with the 5-HPETE product being re-utilized by the LTA4 synthase reaction of 5-lipoxygenase under conditions of limiting arachidonic acid availability. Phospholipids 79-91 arachidonate 5-lipoxygenase Homo sapiens 177-191 6088299-9 1984 In addition, modulation of phospholipids could serve to activate a protein kinase C. Finally, phospholipids can serve as a source for arachidonic acid, which is metabolized by a 5-lipoxygenase pathway in the neutrophil. Phospholipids 27-40 arachidonate 5-lipoxygenase Homo sapiens 178-192 6088299-9 1984 In addition, modulation of phospholipids could serve to activate a protein kinase C. Finally, phospholipids can serve as a source for arachidonic acid, which is metabolized by a 5-lipoxygenase pathway in the neutrophil. Phospholipids 94-107 arachidonate 5-lipoxygenase Homo sapiens 178-192